DAVA Oncology’s 10th Whistler Global Summit on Hematologic Malignancies is a five-day meeting comprising presentations by over 60 KOLs. This summit assembles translational researchers, clinical researchers, and key community oncologists to address and discuss the challenges in the rapidly developing areas of hematology and oncology and the evolution of treatment approaches. Featuring didactic lectures, panel discussions, case presentations and debates highlighting individual patient challenges and new approaches designed to overcome these challenges, the summit reviews compelling data on the effects of novel strategies. There has been an explosion of new information, such as CAR -T cells, bi-specifics and agents in development for patients with hematologic malignancies. Incorporating these agents into clinical care is an ever increasing challenge for community oncologists as they treat the individual patient. Presentations will be given by leading experts around the world in the field of hematologic malignancies, who will offer further insight during question and-answer sessions. The challenges encountered in clinical management will be addressed in highly interactive sessions. The virtual attendees can listen to the live presentations and summit real-time questions in the panel discussion. In addition to these leading experts, fellows and junior faculty will have the opportunity to present and discuss their abstracts. Finally, the Whistler Global Summit aims to bridge conversation and collaboration between industry and academia. Supporting industry representatives will have an opportunity to showcase their data on emerging therapies that are being developed in the hematology space in addition to engaging KOLs through various ancillary opportunities.